OEMs and start-ups that seek to bring a biosensor device to the medical market must be strategic in their approach or risk delays and inflated development costs. The design phase is a critical juncture, as decisions made during this stage are often the difference between a commercially successful biosensor device and one destined for significant redesign — or one that might not be viable at all. Read on for Dave Liebl’s seven best practices for starting a design process that fosters commercial success for medical biosensors, as featured in Medical Design Briefs. https://lnkd.in/gUAvv2vB
Second Harvest Heartland
Intricon team members volunteer at Secondharvest Heartland, a food bank in Minnesota that operates across the emergency food chain to distribute healthy food. The organization partners with community resources to help neighbors in Intricon’s headquarters community of St. Paul-Minneapolis thrive. Volunteers from Intricon sort and pack food and provide other assistance to further the mission of Secondharvest and impact people living in low-income households, seniors, and others needing food assistance.
Medical Design & Outsourcing Feature
Power management considerations for developing and scaling smaller, smarter micromedical devices.From mechanical functionality to data operations and wireless communications, effective power management drives continued device innovation. Learn more here in this article by Intricon engineers for Medical Design & Outsourcing magazine. https://tinyurl.com/2p93yu6b
ST. PAUL, Minn. (Feb. 1, 2023) – Intricon, developer and manufacturer of medical devices
powered by smart miniaturized electronics, today announced that it has named Darren Gilmer
senior manager of a new biosensors medical device product development team in the company’s
Biosensors Center of Excellence (CoE).
Since announcing its CoE last month, Intricon has engaged in several new biosensor initiatives,
according to Dave Liebl, chief commercial and technology officer at Intricon. “This new team is
focused on helping companies with biosensor device designs get their devices to market faster,
keeping Design for Manufacturing, quality and regulatory requirements in mind every step of the
way,” said Liebl.
Gilmer was most recently senior manager of manufacturing engineering at Intricon. He has three
decades of experience growing the company’s expertise in creating sensor-driven devices that
are smaller, lighter, and more comfortable for patients. “The biosensor device market is very
complex,” said Gilmer. “There’s not yet agreement on definitions and standardizations, for
example, which makes it challenging to bring a new device to operability or convert a consumer
biosensor device for a medical application.” Gilmer and his team of engineers are focused on
helping companies overcome these challenges and capture the significant opportunities of the
rapidly growing biosensor category.
About Intricon
For four decades, Intricon has improved and extended people’s lives by developing and
manufacturing sensor-driven micromedical devices. Intricon partners with medical device
companies, providing unique microelectronic expertise — including miniature molding through
final assembly – and regulatory guidance, supply chain optimization, and scalable production,
exclusively for the medical market. Intricon brings the world’s smallest, smartest new and next
generation devices to life.
ST. PAUL, Minn. (Jan. 25, 2023) — Intricon, developer and manufacturer of medical devices
powered by smart miniaturized electronics, announces that Len Desmond has joined the
company as an embedded wireless engineer, on its new Biosensor Center of Excellence, a
business dedicated to bringing medical biosensor devices to market. Desmond joins the Intricon
team as a subject matter expert on electrical, firmware, and PCB layout for the biosensors and
ear-worn device groups.
Desmond has 30 years of biosensor product design, development, and production experience. He
specializes in low battery powered wearable wireless biosensor devices and has extensive
experience designing products with a multitude of different sensors for both large OEMs and
startups. He is steeped in numerous certifications including FCC, CE, UL, ATEX, IECEx, and
CCC, which will contribute to Intricon’s consulting on requirements for the commercialization of
biosensor devices for medical applications.
Prior to joining Intricon, Desmond was director of engineering and system architect at
International ThermoDyne, working closely with contract developers on software and firmware.
He was also responsible for domestic and international supply chains, including international
sourcing and production management. He has been a principal hardware/firmware design
engineer and team leader, RF product engineer, with deep expertise in successful manufacturing
transfers of biosensor-driven devices.
“It’s an exciting time at Intricon and in the medical biosensor device sector,” said Scott Longval,
chief executive officer at Intricon. “Even though we have four decades of experience in body-
worn device development and manufacturing, we stay ahead of what’s coming next. Biosensors
is the hottest new med device category. The standards and requirements aren’t even established
yet, so it’s important for companies waiting to take advantage of this opportunity to partner with
us to guide them through the stages to market.”
Intricon recently announced its Biosensors Center of Excellence and new vice president of
operations who will manage the company’s global capacity to develop and manufacturer medical
biosensor devices.
About Intricon
For four decades, Intricon has improved and extended people’s lives by developing and
manufacturing sensor-driven micromedical devices. Intricon partners with medical device
companies, providing unique microelectronic expertise — including miniature molding through
final assembly – and regulatory guidance, supply chain optimization, and scalable production,
exclusively for the medical market. Intricon brings the world’s smallest, smartest new and next
generation devices to life.
ST. PAUL, Minn. (Jan. 17, 2023) – Intricon, developer and manufacturer of medical devices powered by smart miniaturized electronics, today announced that it has launched a new Biosensors Center of Excellence (CoE). The new CoE combines Intricon’s biosensor device expertise and capabilities into a vertically integrated business unit focused exclusively on bringing Biosensor devices to the medical market.
“OEMs and start-ups need an approach like this because there are important intricacies in
creating medical biosensor devices vs. consumer biosensor products,” said Scott Longval,
Intricon CEO. “There’s a mass movement toward biosensors for medical applications, such as hospital at home and remote patient monitoring. Creating and commercializing first- and next-generation medical biosensor devices are more complex than ever and must happen at scale and cost profile to meet the demands of these exploding use cases.”
Longval adds that Intricon’s intensified focus on biosensors is a natural evolution for the
company, given its more than four decades of experience in wearable medical biosensor devices. Intricon was an early innovator of hearing aids — the precursor to today’s modern body-worn devices — and is the primary developer and manufacturer of wearable glucose monitoring devices for the world’s largest med device company.
“We’re responding to the industry, which needs deep expertise in the many complex capabilities required to successfully compete in this quickly emerging device category,” said Dave Liebl, Intricon chief commercial and technology officer.
The Intricon Biosensor CoE team has deep expertise in high-density microelectronics,
miniaturization, ultra-low power, miniature molding, firmware development, and wireless
communication, including Bluetooth and Bluetooth Low Energy technology. Intricon plans to expand its team of biosensors experts, with key hires in 2023.
Intricon’s other sensor-driven expertise is in developing and manufacturing medical devices that use electromagnetic (EM) navigation. The company has proprietary modeling and engineering systems to design and produce micro-coils that meet electromagnetic goals such as induction, resistance, sensitivity, and localization performance.
About Intricon
For four decades, Intricon has improved and extended people’s lives by developing and
manufacturing sensor-driven micromedical devices. Intricon partners with medical device
companies, providing unique microelectronic expertise — including miniature molding through final assembly – and regulatory guidance, supply chain optimization, and scalable production, exclusively for the medical market. Intricon brings the world’s smallest, smartest new and next generation devices to life.
MedTech Outlook media recently interviewed Intricon Chief Commercial and Technology Officer Dave Liebl about the biosensors medical market. Intricon is uniquely positioned to help companies accelerate medical device manufacturing and innovation given its four-plus decades of experience in body worn devices. Learn more about the considerations for commercializing biosensor devices as the market for their uses continues to grow. Read the article here (https://tinyurl.com/294dtsf4).
On behalf of Intricon, Todd Latterell, senior director of corporate accounts, recently accepted the 2022 Extraordinary Supplier Award from Ethicon, a Johnson & Johnson (J&J) Medtech Company, at the most recent annual J&J Supplier Symposium. Julio Fiori, new product introduction sourcing manager for J&J’s Auris Health business, presented the award. Intricon teams from the U.S. and Singapore – including those from Customer Service, Manufacturing, Product Development, Supply Chain, and Quality – contributed to this achievement. Intricon was among only four companies throughout the world to be recognized by J&J, a company thatdrives breakthrough scientific innovation to address unmet needs and reimagine health in surgery, orthopedics, vision, and interventional solutions.
